In October 2013, the development of sitafloxacin API and tablet products was initiated
In August 2015 to start Tianan four API products production technology transfer work
Developed in October 2015 for the development of combination of fengomodine hydrochloride and sitagliptin metformin tablets
2016 April started with Fudan University to develop the development of new technologies for the synthesis of statins
In May 2016, he initiated the co-development of the new film
October 2016 to obtain calcium benzenesulfonate raw material production license
In December 2016, the production license for azinemide, glimepiride and repaglinide was obtained.
In January 2017, the process validation of calcium benzenesulfonate was completed